Search academic texts

Information × Registration Number 0201U001790, 0197U014644 , R & D reports Title Phensuccinal - perspective agent for prevention or delay of insulindependent diabetes mellitus (type 1) clinical manifestation popup.stage_title Head Poltorak V. V., Registration Date 20-02-2001 Organization Ukrainian Research Institute of Endocrine Diseases Pharmacotherapy popup.description2 Object: biologically active compound - phensuccinal. Aim: the development of novel medical form of medicine for prevention and delay of insulindependent diabetes clinical manifestation. Methods: organic synthesis, physic-chemical analysis, biochemical, histological, pharmacological. Results: the technology of phensuccinal novel medical form has been developed and recommendation for phensuccinal clinical trial in children has been grounded. Efficacy: enlargement of medicines for prevention of type 1 diabetes mellitus. Field of using: care of public Product Description popup.authors popup.nrat_date 2020-04-02 Close